Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Ascencio Sca | ASC | Mar 28, 2024 | 50.90 | 0.00 |
Ascencio Sca | ASCE | Mar 28, 2024 | 47.60 | +1.17 |
ASIT biotech SA | ASIT | Mar 28, 2024 | 0.23 | 0.00 |
Assicurazioni Generali SpA | GEN | Mar 28, 2024 | 19.50 | 0.00 |
Atenor | ATEB | Mar 28, 2024 | 6.66 | +2.15 |
AVANTIUM | AVTX | Mar 28, 2024 | 2.11 | +1.44 |
Azelis Group NV | AZE | Mar 28, 2024 | 19.59 | -0.41 |
Balta Group N.V. | BALTA | Mar 28, 2024 | 1.36 | 0.00 |
Banco Bilbao Vizcaya Argentaria SA | BBV | Mar 28, 2024 | 7.80 | 0.00 |
Banco Santander SA | SANTA | Mar 28, 2024 | 3.58 | 0.00 |
Banimmo SA | BANI | Mar 28, 2024 | 3.34 | +3.09 |
Banque Nationale de Belgique | BNB | Mar 28, 2024 | 470.00 | -4.86 |
Barco NV | BAR | Mar 28, 2024 | 15.27 | +0.73 |
Basilix | BAS | Mar 28, 2024 | 13.60 | 0.00 |
Beaulieu Av Certificates | BEAB | Mar 28, 2024 | 1.19 | 0.00 |
Befimmo SA | BEFB | Mar 28, 2024 | 46.10 | 0.00 |
Bel20 | BEL20 | Mar 28, 2024 | 3 845.63 | +0.33 |
Belreca - Belgian Resources and Capital Company | BELR | Mar 28, 2024 | 7.50 | 0.00 |
Beluga NV | BELU | Mar 28, 2024 | 2.00 | 0.00 |
Belysse Group N.V. | BELYS | Mar 28, 2024 | 0.88 | +11.96 |
Biocartis Group NV | BCART | Mar 28, 2024 | 0.29 | 0.00 |
Biosenic | BIOS | Mar 28, 2024 | 0.02 | 0.00 |
Biotalys | BTLS | Mar 28, 2024 | 3.08 | +1.32 |
Boeing | BOEI | Mar 28, 2024 | 224.00 | 0.00 |
Bone Therapeutics S.A. | BOTHE | Mar 28, 2024 | 0.29 | 0.00 |
Bpost S.A. / N.V | BPOST | Mar 28, 2024 | 3.46 | +0.17 |
Brederode S.A. | BREB | Mar 28, 2024 | 104.80 | +1.75 |
Campine nv | CAMB | Mar 28, 2024 | 67.00 | -0.74 |
Candela Invest | CAND | Mar 28, 2024 | 2.90 | 0.00 |
Care Property Invest NV/SA | CPINV | Mar 28, 2024 | 13.20 | +3.45 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.